Contrast-enhanced endoscopic ultrasound in the differential
diagnosis of pancreatic cystic lesions

a 2023

Contrast-enhanced endoscopic ultrasound in the differential diagnosis of pancreatic cystic lesions

ZOUNDJIEKPON, Vincent, Lumír KUNOVSKÝ, Silvia CVEKOVA, Tomas TICHY, Petr VANEK et. al.

Základní údaje

Originální název

Contrast-enhanced endoscopic ultrasound in the differential diagnosis of pancreatic cystic lesions

Autoři

ZOUNDJIEKPON, Vincent, Lumír KUNOVSKÝ, Silvia CVEKOVA, Tomas TICHY, Petr VANEK, Peter SLODICKA, Jana ZAPLETALOVA, Namrata GURUNG, Pavel SKALICKY, Premysl FALT a Ondrej URBAN

Vydání

European Pancreatic Club 2023, 2023

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30219 Gastroenterology and hepatology

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 3.600 v roce 2022

Organizační jednotka

Lékařská fakulta

ISSN

DOI

http://dx.doi.org/10.1016/j.pan.2023.06.674

Příznaky

Mezinárodní význam

Změněno: 30. 10. 2023 14:18, Mgr. Tereza Miškechová

Anotace

V originále

Background: The differential diagnosis of some pancreatic cystic lesions remains difficult. In these cases, contrast-enhanced endoscopic ultrasound (CE-EUS) was proven to be useful. This study aims to evaluate the accuracy of CE-EUS for diagnosing pancreatic cystic lesions with a suspicion of risk factors for malignancy. Methods: A retrospective analysis of patients with suspected pancreatic cystic neoplasms who underwent a CE-EUS at the University Hospital Olomouc from January 2020 - February 2022 was performed. The final diagnosis of cystic lesion was then confirmed using other cross-sectional imaging methods, cytologic, and biochemical findings by EUS fine needle aspiration, postoperative histology, or the long-term follow-up of the patients. Results: During the study period, EUS was performed in a total of 167 patients with a pancreatic cystic lesion. 29 patients (17.4%) were then referred for CE-EUS for suspected risk features. Enhancement was observed in 9/29 patients (31%), from which 4 patients were operated on with a confirmation of a premalignant or malignant diagnosis. Twenty patients (69%) were without enhancement, from which one patient (5%) was operated on with a confirmation of premalignancy. The remaining 19 patients were referred to follow-up. In this group, 2 (10.5%) patients had a premalignant cystic lesion, and 17 (89.5%) patients had a benign diagnosis. No complications were reported during the procedure. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of CE-EUS were 70%, 89.5%, 77.8%, 85% and 82.8%, respectively. Conclusion: CE-EUS is a feasible and safe method used for the differential diagnosis of suspected pancreatic cystic neoplasms to guide further treatment. However, the results are limited by a low number of provided CE-EUS, and a prospective randomised study with more patients is necessary to confirm these results.

Citovat

ZOUNDJIEKPON, Vincent, Lumír KUNOVSKÝ, Silvia CVEKOVA, Tomas TICHY, Petr VANEK, Peter SLODICKA, Jana ZAPLETALOVA, Namrata GURUNG, Pavel SKALICKY, Premysl FALT a Ondrej URBAN. Contrast-enhanced endoscopic ultrasound in the differential diagnosis of pancreatic cystic lesions. In European Pancreatic Club 2023. 2023. ISSN 1424-3903. Dostupné z: https://dx.doi.org/10.1016/j.pan.2023.06.674.

@proceedings{2332038,
   author = {Zoundjiekpon, Vincent and Kunovský, Lumír and Cvekova, Silvia and Tichy, Tomas and Vanek, Petr and Slodicka, Peter and Zapletalova, Jana and Gurung, Namrata and Skalicky, Pavel and Falt, Premysl and Urban, Ondrej},
   booktitle = {European Pancreatic Club 2023},
   doi = {http://dx.doi.org/10.1016/j.pan.2023.06.674},
   language = {eng},
   title = {Contrast-enhanced endoscopic ultrasound in the differential diagnosis of pancreatic cystic lesions},
   url = {https://www.sciencedirect.com/science/article/pii/S1424390323014126},
   year = {2023}
}

TY  - CONF
ID  - 2332038
AU  - Zoundjiekpon, Vincent - Kunovský, Lumír - Cvekova, Silvia - Tichy, Tomas - Vanek, Petr - Slodicka, Peter - Zapletalova, Jana - Gurung, Namrata - Skalicky, Pavel - Falt, Premysl - Urban, Ondrej
PY  - 2023
TI  - Contrast-enhanced endoscopic ultrasound in the differential diagnosis of pancreatic cystic lesions
UR  - https://www.sciencedirect.com/science/article/pii/S1424390323014126
N2  - Background: The differential diagnosis of some pancreatic cystic lesions remains difficult. In these cases, contrast-enhanced endoscopic ultrasound (CE-EUS) was proven to be useful. This study aims to evaluate the accuracy of CE-EUS for diagnosing pancreatic cystic lesions with a suspicion of risk factors for malignancy. Methods: A retrospective analysis of patients with suspected pancreatic cystic neoplasms who underwent a CE-EUS at the University Hospital Olomouc from January 2020 - February 2022 was performed. The final diagnosis of cystic lesion was then confirmed using other cross-sectional imaging methods, cytologic, and biochemical findings by EUS fine needle aspiration, postoperative histology, or the long-term follow-up of the patients. Results: During the study period, EUS was performed in a total of 167 patients with a pancreatic cystic lesion. 29 patients (17.4%) were then referred for CE-EUS for suspected risk features. Enhancement was observed in 9/29 patients (31%), from which 4 patients were operated on with a confirmation of a premalignant or malignant diagnosis. Twenty patients (69%) were without enhancement, from which one patient (5%) was operated on with a confirmation of premalignancy. The remaining 19 patients were referred to follow-up. In this group, 2 (10.5%) patients had a premalignant cystic lesion, and 17 (89.5%) patients had a benign diagnosis. No complications were reported during the procedure. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of CE-EUS were 70%, 89.5%, 77.8%, 85% and 82.8%, respectively. Conclusion: CE-EUS is a feasible and safe method used for the differential diagnosis of suspected pancreatic cystic neoplasms to guide further treatment. However, the results are limited by a low number of provided CE-EUS, and a prospective randomised study with more patients is necessary to confirm these results.
ER  -

ZOUNDJIEKPON, Vincent, Lumír KUNOVSKÝ, Silvia CVEKOVA, Tomas TICHY, Petr VANEK, Peter SLODICKA, Jana ZAPLETALOVA, Namrata GURUNG, Pavel SKALICKY, Premysl FALT a Ondrej URBAN. Contrast-enhanced endoscopic ultrasound in the differential diagnosis of pancreatic cystic lesions. In \textit{European Pancreatic Club 2023}. 2023. ISSN~1424-3903. Dostupné z: https://dx.doi.org/10.1016/j.pan.2023.06.674.

Podrobný výpis o publikaci